Related Experiment Videos
Microflora in inflammatory bowel diseases: a pediatric perspective.
Eugenia Bruzzese1, Roberto Berni Canani, Giulio De Marco
1Department of Pediatrics, University Federico II, Naples, Italy.
Journal of Clinical Gastroenterology
|June 29, 2004
Summary
Modifications in gut bacteria are linked to inflammatory bowel diseases (IBD). Probiotics may help educate the developing immune system, potentially reducing IBD risk and recurrence in children.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Inflammatory bowel diseases (IBD) like ulcerative colitis and Crohn disease are associated with altered intestinal microflora.
- Experimental models show intestinal microorganisms are essential for inflammation development in IL-10 knockout mice, with shifts in specific bacterial populations.
Purpose of the Study:
- To investigate the interaction between intestinal microflora and the immune system in children with or at risk for IBD.
- To explore novel strategies for immune system education during early development to manage intestinal inflammation.
Main Methods:
- Review of existing epidemiological, clinical, and experimental evidence linking gut microbiota to IBD.
- Analysis of the role of microbiologic imprinting in neonates and the potential of probiotics.
Main Results:
- Gut microbiota changes are implicated in IBD pathogenesis.
- Probiotics may modify immune responses, reduce atopy risk, and potentially decrease IBD recurrence.
- Preliminary anti-inflammatory effects of probiotics observed in pediatric cystic fibrosis patients.
Conclusions:
- Understanding the gut-immune axis in early life is crucial for IBD pathophysiology.
- Targeting microbiologic imprinting with probiotics offers a potential strategy for preventing and managing IBD in children.